Index Management Solutions’s Agios Pharmaceuticals AGIO Stock Holding History

Index Management Solutions’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$3K	Buy	+42	New	+$4.11K	﹤0.01%	666

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Index Management Solutions's AGIO Position: Q3 2015 in Review

Index Management Solutions opened a new position in Agios Pharmaceuticals (AGIO) in Q3 2015: 42 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #666 among its holdings.

150 funds tracked by Wall St. Rank hold AGIO as of Q3 2015.

Index Management Solutions held 42 shares of Agios Pharmaceuticals worth $3K as of Q3 2015.
Agios Pharmaceuticals was a new Index Management Solutions position in Q3 2015.
Agios Pharmaceuticals made up ﹤0.01% of Index Management Solutions's portfolio in Q3 2015, its #666 holding.
150 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2015.

Based on Index Management Solutions's 13F filing for Q3 2015, filed 13 Nov 2015.